Lesley A Ogilvie
Publications
2019
Chetwynd AJ, Ogilvie LA, Nzakizwanayo J, Pazdirek F, Hoch J, Dedi C, Pazdirek F, Hoch J, Dedi C, Gilbert D, Abdul-Sada A, Jones BV, Hill EM. The potential of nanoflow liquid chromatography-nano electrospray ionisation-mass spectrometry for global profiling the faecal metabolome Journal of Chromatography A 1600, 127-136
Alves DR, Nzakizwanayo J, Dedi C, Olympiou C, Hanin A, Kot W, Hestbjerg Hansen L, Lametsch R, Gahan CGM, Schellenberger P, Ogilvie LA, Jones BV
Genomic and ecogenomic characterisation of Proteus mirabilis bacteriophage. Frontiers in Microbiology 10, 1783
2018
Ogilvie LA, Nzakizwanayo J, Guppy F, Dedi C, Diston D, Taylor H, Ebdon J, Jones BV. Resolution of habitat-associated ecogenomic signatures in bacteriophage genomes and application to microbial source tracking. The ISME journal 12 (4), 942.
2017
Ogilvie LA, Jones BVJ. The human gut virome: form and function. Emerging Topics in Life Sciences 1 (4), 351-362.
Ogilvie LA, Kovachev A, Wierling C, Lange BMH, Lehrach H. Models of models: translational route for cancer treatment and drug development. Front . Oncol. 2017 7;7:219. doi: 10.3389/fonc.2017.00219.
Ogilvie LA, Jones BV (2017) Revisiting Enterotypes: A viral perspective. Future Virology 12(8), 391-394. doi.org/10.2217/fvl-2017-0056
Schütte M, Ogilvie LA, Rieke DT, Lange B. Yaspo ML, Lehrach H (2017). Cancer precision medicine: why more is more and DNA is not enough. Public Health Genomics. doi: 10.1159/000477157.
Lehrach H, Kessler T, Ogilvie LA, Schütte M, Wierling C. (2017) Modelling molecular mechanisms of cancer pathogenesis: virtual patients, real opportunities. Mechanisms in Carcinogenesis - Volume 2, Springer Ed Haybäck, Johannes (Ed.) pp 359-374..doi: 10.1007/978-3-319-53661-3
2015
Ogilvie, L.A., Wierling, C., Kessler, T., Lehrach, H., Lange, B.M.H. (2015) Predictive Modeling of Drug Treatment in the Area of Personalized Medicine.
Cancer Informatics 14(S4) 95–103 doi: 10.4137/CIN.S19330
Ogilvie, L.A., and Jones, B.V. The human gut virome: a multifaceted majority.Front. Microbiol. 6:918. doi:10.3389/fmicb.2015.00918
Wierling, C., Kessler, T., Ogilvie, L.A., Lange, B.M.H., Yaspo, M.L., Lehrach, H. Network and systems biology: essential steps in virtualising drug discovery and development. Drug Discovery Today: Technologies 15, 33-40. doi:10.1016/j.ddtec.2015.07.002
Nzakizwanayo J, Kumar S, Ogilvie LA, Patel BA, Dedi C, Macfarlane WM, Jones BV. Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health. PLoS One. 2015 Mar 19;10(3):e0120430. doi: 10.1371/journal.pone.0120430. eCollection 2015.
2014
Fouhy, F., Ogilvie, L.A., Jones, B.V., Ross, R.P., Ryan, A.C., Dempsey, E.M., Fitzgerald, G.F., Stanton, C., Cotter, P.D. Identification of aminoglycoside and β-lactam resistance genes from within an infant gut functional metagenomic library. PLoS One 9(9):e108016. doi: 10.1371/journal.pone.0108016. eCollection 2014.
Henderson D, Ogilvie LA, Hoyle N, Keilholz U, Lange B, Lehrach H. Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack. Biotechnol J. ;9(9):1104-14. doi: 10.1002/biot.201400109.
Ogilvie LA, Jones BVJ. The Human Gut mobile Metagenome: A Metazoan Perspective. In Encyclopedia of Metagenomics, ed Sarah Highlander. Springer Science+Business Media New York 2013. pp1-14. DOI. 10.1007/978-1-4614-6418-1_782_1.
Buelow E, Gonzalez TB, Versluis D, Oostdijk EA, Ogilvie LA, van Mourik MS, Oosterink E, van Passel MW, Smidt H, D'Andrea MM, de Been M, Jones BV, Willems RJ, Bonten MJ, van Schaik W. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother. 69(8):2215-23. doi: 10.1093/jac/dku092.
Holling, N., Lednor, D., Tsang, S., Bissell, A., Campbell, L., Nzakizwanayo, J., Dedi, C., Hawthorne, J., Hanlon, G., Ogilvie, L.A., Salvage, J., Patel, B., Barnes, L., Jones, B.V. : Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis. Infection and Immunity. 82(4):1616-26. doi: 10.1128/IAI.01652-13.
2013
Ogilvie LA, Caplin J, Dedi C, Diston D, Cheek E, Bowler L, Taylor H, Ebdon J, Jones BV (2013) Genome signature-based dissection of metagenomic datasets to extract subliminal viral sequences. Nature Communications 4: 2420.
2012
Ogilvie LA, Jones BV (2012) Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Gut 61(11):1642-1643.
Ogilvie LA, Firouzmand S, Jones BV (2012) Evolutionary, ecological, and biotechnological perspectives on plasmids resident in the human gut mobile metagenome. Bioengineered Bugs 3(1):13-31
Ogilvie LA, Caplin J, Dedi C, Diston D, Cheek E, Bowler L, Taylor H, Ebdon J, Jones BV (2012) Comparative (meta)-genomic analysis and ecological profiling of human gut-specific bacteriophage B124-14. PLoS ONE 7(4):e35053.
Ogilvie LA, Hirsch P (2012) Microbial Ecological Theory: Current Perspectives. Norwich, UK: Caister Academic Press. 120 p.
2011
Dietrich M, Bartfeld S, Munke R, Lange C, Ogilvie LA, Friedrich A, Meyer TF (2011) Activation of NF-κB by Neisseria gonorrhoeae is associated with microcolony formation and type IV pilus retraction. Cell Microbiol 13(8):1168-1182.
2010
Fassi Fehri L, Mak TN, Laube B, Brinkmann V, Ogilvie LA, Mollenkopf H, Lein M, Schmidt T, Meyer TF, Brüggemann H (2010) Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol 301(1):69-78.
Sörensen M, Mak TN, Hurwitz R, Ogilvie LA, Mollenkopf HJ, Meyer TF, Brüggemann H (2010). Mutagenesis of Propionibacterium acnes and analysis of two CAMP factor knock-out mutants. J Microbiol Methods 83(2):211-216.
Bartfeld S, Hess S, Bauer B, Machuy N, Ogilvie LA, Schuchhardt J, Meyer TF (2010) High-throughput and single-cell imaging of NF-kB oscillations using monoclonal cell lines. BMC Cell Biol 11:21.
Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Mäurer AP, Müller E, Wolff T, Rudel T, Meyer TF (2010) Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463(7282):818-822.
Ogilvie LA, Heuer D, Meyer TF (2010) Chlamydia: from molecular insight to therapeutic discovery. In Sansonetti P, editor. Bacterial virulence: Basic Principles, Models and Global Approaches. Weinheim: WILEY-VCH Verlag GmbH & Co KgaA. pp. 165-182.
Ogilvie LA, Hirsch P (2010) Microbial diversity: Methods and meaning. In Trepper GH, editor. Species diversity and Extinction. New York, USA: Nova Science Publishers. pp. 215-238.
2008
Ogilvie LA, Hirsch P, Johnston A (2008) Bacterial diversity of the Broadbalk 'classical' winter wheat experiment in relation to long-term fertilizer inputs. Microb Ecol 56(3):525-537.
Ogilvie LA, Grant A (2008) Linking pollution induced community tolerance (PICT) and microbial community structure in chronically metal polluted estuarine sediments. Mar Environ Res 65(2):187-198.
2005
Johnston AWB, Li Y, Ogilvie LA (2005) Metagenomic marine nitrogen fixation - feast or famine? Trends in Microbiol 13:416-420.
2004
Grant A, Ogilvie LA (2004) Name that microbe: Rapid identification of taxa responsible for individual fragments in T-RFLP, LH-PCR and ARISA fingerprints of microbial community structure. Mol Ecol Notes 4(1):133-136.
2003
Grant A, Ogilvie LA (2003) Terminal restriction fragment length polymorphism data analysis. Appl Environ Microbiol 69(10):6342; author reply 6342-6343.
Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie
Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie
Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie
Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie Lesley A Ogilvie